• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗后胃肠道功能变化管理中的临床决策:经验是否足够?

Clinical decision-making in managing changes in gastrointestinal function following cancer therapies: Is experience enough?

作者信息

Muls A C, Klimova K, Andreyev H J N

机构信息

The GI Unit, The Royal Marsden NHS Foundation Trust, London, UK.

出版信息

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12766. Epub 2017 Sep 11.

DOI:10.1111/ecc.12766
PMID:28892252
Abstract

In patients with gastrointestinal (GI) disorders, identical symptoms may occur for many different reasons. This prospective study assessed whether experienced clinicians can predict accurately the underlying diagnosis or diagnoses contributing to specific symptoms based on the history and physical examination. Three clinicians assessed 47 patients referred for management of troublesome GI symptoms identified after treatment for cancer. Investigations were requested following our comprehensive, peer-reviewed algorithm. The clinicians then recorded their predictions as to the results of those investigations. After each patient had completed all their investigations, had received optimal management and had been discharged from the clinic, the predicted diagnoses were compared to those made. The clinicians predicted 92 diagnoses (1.9 per patient). After investigation, a total of 168 unique diagnoses were identified (3.5 per patient). Of the 92 predicted diagnoses, 41 (43%) matched the diagnosis. Of the 168 actual diagnoses identified, only 24% matched the prediction. None of the clinicians predicted the correct combination of diagnoses contributing to bowel symptoms. Clinical acumen alone is inadequate at determining cause for symptoms in patients with GI symptoms developing after cancer therapy.

摘要

在患有胃肠道(GI)疾病的患者中,许多不同原因可能导致相同的症状。这项前瞻性研究评估了经验丰富的临床医生是否能够根据病史和体格检查准确预测导致特定症状的潜在诊断。三位临床医生对47例因癌症治疗后出现令人困扰的胃肠道症状而前来就诊的患者进行了评估。按照我们经过同行评审的综合算法进行了相关检查。然后,临床医生记录他们对这些检查结果的预测。在每位患者完成所有检查、接受了最佳治疗并从诊所出院后,将预测诊断与实际诊断进行比较。临床医生共预测了92个诊断(每位患者1.9个)。经过检查,共确定了168个不同的诊断(每位患者3.5个)。在92个预测诊断中,有41个(43%)与实际诊断相符。在确定的168个实际诊断中,只有24%与预测相符。没有一位临床医生预测出导致肠道症状的正确诊断组合。仅靠临床敏锐度不足以确定癌症治疗后出现胃肠道症状的患者的症状原因。

相似文献

1
Clinical decision-making in managing changes in gastrointestinal function following cancer therapies: Is experience enough?癌症治疗后胃肠道功能变化管理中的临床决策:经验是否足够?
Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12766. Epub 2017 Sep 11.
2
Outcomes from treating bile acid malabsorption using a multidisciplinary approach.采用多学科方法治疗胆汁酸吸收不良的结果。
Support Care Cancer. 2015 Oct;23(10):2881-90. doi: 10.1007/s00520-015-2653-5. Epub 2015 Feb 20.
3
Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?盆腔放疗后的胃肠道症状:胃肠病学家的作用?
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1464-71. doi: 10.1016/j.ijrobp.2004.12.087.
4
Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.癌症治疗相关急性和慢性胃肠道问题管理实践指南。
Gut. 2012 Feb;61(2):179-92. doi: 10.1136/gutjnl-2011-300563. Epub 2011 Nov 4.
5
Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.盐酸考来维仑治疗癌症患者胆汁酸吸收不良的有效性和耐受性:回顾性图表分析和患者问卷调查。
Clin Ther. 2009 Nov;31(11):2549-58. doi: 10.1016/j.clinthera.2009.11.027.
6
The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?胃肠与营养团队对癌症治疗后果的整体管理:一种解决重大问题的经济可行方法?
Clin Med (Lond). 2016 Jun;16(3):240-6. doi: 10.7861/clinmedicine.16-3-240.
7
Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.癌症治疗后胃肠道症状的管理:胃肠病学家的实用方法
Frontline Gastroenterol. 2013 Jan;4(1):57-68. doi: 10.1136/flgastro-2012-100218. Epub 2012 Oct 2.
8
Hemispheric activation differences in novice and expert clinicians during clinical decision making.新手和专家临床医生在临床决策过程中的半球激活差异。
Adv Health Sci Educ Theory Pract. 2016 Dec;21(5):921-933. doi: 10.1007/s10459-015-9648-3. Epub 2015 Nov 3.
9
Gastrointestinal consequences of cancer treatment: evaluation of 10 years' experience at a tertiary UK centre.癌症治疗的胃肠道后果:英国一家三级中心的10年经验评估
Frontline Gastroenterol. 2020 Aug 11;12(6):471-477. doi: 10.1136/flgastro-2020-101430. eCollection 2021.
10
Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling.肿瘤学期刊演讲。癌症治疗的胃肠道后果及更广泛的背景:一种糟糕的肠胃感觉。
Acta Oncol. 2014 Mar;53(3):297-306. doi: 10.3109/0284186X.2013.873140. Epub 2014 Jan 27.

引用本文的文献

1
British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer.英国胃肠病学会关于癌症治疗所致急慢性胃肠道症状及并发症管理的实践指南。
Gut. 2025 Jun 6;74(7):1040-1067. doi: 10.1136/gutjnl-2024-333812.
2
Nivolumab-induced exocrine pancreatic insufficiency.纳武单抗诱发的外分泌性胰腺功能不全。
Frontline Gastroenterol. 2021 Dec 20;14(2):167-170. doi: 10.1136/flgastro-2021-102013. eCollection 2023.
3
The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy.
FOCCUS 研究:化疗期间和之后胃肠道症状的频率、严重程度和可治疗原因的前瞻性评估。
Support Care Cancer. 2021 Mar;29(3):1443-1453. doi: 10.1007/s00520-020-05610-x. Epub 2020 Jul 16.